|Grant Affiliation:||Weiss: Protection by Neutralizing Antibodies|
|Strategy:||Protein & peptide vaccines|
|Study Type:||Pre-Clinical Non-NHP|
|Study Start Date:||2008-09-24|
|Study Made Public:||2011-08-08|
The effect of mixing novel HIV envelope antigens on the quality of neutralising antibody responses in rabbits.
CAVD 319 is a preclinical rabbit study assessing 3 newly isolated HIV strains for immunizing potential, in comparison with CN54 gp140. None of the new strains proved as immunogenic as CN54.
Sign in to see full information about this study and to download study data.
ProductsProduct info coming soon!
No integrated data is available for this study.
No non-integrated data is available for this study.